In the most recent issue of BIOTECanada’s Insights Magazine, we talk about how a new sugar-based breast-cancer imaging agent set to enter human trials highlights opportunities to streamline the path from lab to clinic.
Trouble viewing? Try this link.
Read the full issue of Insights Magazine.